Autonomic nervous system arousal and cognitive functioning in bipolar disorder

Bipolar Disorders

Volumn 15, Issue 1, 2013, Pages 70-79

  Levy, Boaz ^a  

^a UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

Author keywords

Anxiety; Autonomic nervous system; Bipolar disorder; Cognitive impairment; Sympathetic arousal

Indexed keywords

ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; LITHIUM; NEUROLEPTIC AGENT;

ADULT; ALCOHOL USE DISORDER; ANXIETY; AROUSAL; ARTICLE; ATTENTION; AUTONOMIC NERVOUS SYSTEM; BECK DEPRESSION INVENTORY; BIPOLAR DISORDER; CLINICAL ARTICLE; COGNITION; CORRELATION ANALYSIS; ELECTRODE; ELECTRODERMAL RESPONSE; ELECTROGRAPHY; FEMALE; HUMAN; MALE; MEMORY; MOOD DISORDER; NEUROPSYCHOLOGY; PRIORITY JOURNAL; SCORING SYSTEM; TEMPERATURE; THERMOMETER; WORKING MEMORY; YOUNG MANIA RATING SCALE;

ADOLESCENT; ADULT; AUTONOMIC NERVOUS SYSTEM DISEASES; BIPOLAR DISORDER; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 84872648712     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12028     Document Type: Article

References (60)

1. Mur M, Portella MJ, Martínez-Arán A, Pifarré J, Vieta E. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients. J Clin Psychiatry 2008; 69: 712-719.
2. Torres IJ, Boudreau VG, Yatham LN. Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand Suppl 2007; 434: 17-26.
3. Martinez-Aran A, Vieta E, Reinares M et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004; 16: 262-270.
4. Mur M, Portella MJ, Martínez-Arán A, Pifarré J, Vieta E. Persistent neuropsychological deficit in euthymic bipolar patients: executive function as a core deficit. J Clin Psychiatry 2007; 68: 1078-1086.
5. Clark L, Iversen SD, Goodwin GM. Sustained attention deficit in bipolar disorder. Br J Psychiatry 2002; 180: 313-319.
6. Robinson LJ, Thompson JM, Gallagher P et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 2006; 93: 105-115.
7. Arnone D, Cavanagh J, Gerber D, Lawrie SM, Ebmeier KP, McIntosh AM. Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br J Psychiatry 2009; 195: 194-201.
8. Townsend J, Bookheimer SY, Foland-Ross LC, Sugar CA, Altshuler LL. fMRI abnormalities in dorsolateral prefrontal cortex during a working memory task in manic, euthymic and depressed bipolar subjects. Psychiatry Res 2010; 182: 22-29.
9. Bruno SD, Papadopoulou K, Cercignani M, Cipolotti L, Ron MA. Structural brain correlates of IQ changes in bipolar disorder. Psychol Med 2006; 36: 609-618.
10. Moorhead TW, McKirdy J, Sussmann JE et al. Progressive gray matter loss in patients with bipolar disorder. Biol Psychiatry 2007; 62: 894-900.
11. Martinez-Arán A, Vieta E, Colom F et al. Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord 2004; 6: 224-232.
12. Malhi GS, Ivanovski B, Hadzi-Pavlovic D, Mitchell PB, Vieta E, Sachdev P. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. Bipolar Disord 2007; 9: 114-125.
13. Robinson LJ, Ferrier IN. Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disord 2006; 8: 103-116.
14. Bearden CE, Glahn DC, Monkul ES et al. Patterns of memory impairment in bipolar disorder and unipolar major depression. Psychiatry Res 2006; 142: 139-150.
15. Denicoff KD, Ali SO, Mirsky AF et al. Relationship between prior course of illness and neuropsychological functioning in patients with bipolar disorder. J Affect Disord 1999; 56: 67-73.
16. Cannon M, Jones P, Gilvarry C et al. Premorbid social functioning in schizophrenia and bipolar disorder: similarities and differences. Am J Psychiatry 1999; 154: 1544-1550.
17. Reichenberg A, Weiser M, Rabinowitz J et al. A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. Am J Psychiatry 2002; 59: 2027-2035.
18. Goodwin GM, Martinez-Aran A, Glahn DC et al. Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report. Eur Neuropsychopharmacol 2008; 18: 787-793.
19. McEwen BS, Wingfield JC. The concept of allostasis in biology and biomedicine. Horm Behav 2003; 43: 2-15.
20. Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord 2005; 7: 424-430.
21. McIntyre RS, McElroy SL, Konarski JZ et al. Substance use disorders and overweight/obesity in bipolar I disorder: preliminary evidence for competing addictions. J Clin Psychiatry 2007; 68: 1352-1357.
22. Manove E, Levy B. Cognitive impairment in bipolar disorder: an overview. Postgrad Med 2010; 122: 7-16.
23. Kapczinski F, Vieta E, Andreazza AC et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev 2008; 32: 675-692.
24. Berk M, Kapczinski F, Andreazza AC et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011; 35: 804-807.
25. Simon NM, Otto MW, Wisniewski SR et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2004; 161: 2222-2229.
26. Freeman MP, Freeman SA, McElroy SL. The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. J Affect Disord 2002; 68: 1-23.
27. Baldassano CF. Illness course, comorbidity, gender, and suicidality in patients with bipolar disorder. J Clin Psychiatry 2006; 67 (Suppl. 11): 8-11.
28. McElroy SL, Altshuler LL, Suppes T et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001; 158: 420-426.
29. Pini S, Maser JD, Dell'Osso L et al. Social anxiety disorder comorbidity in patients with bipolar disorder: a clinical replication. J Anxiety Disord 2006; 20: 1148-1157.
30. Coryell W, Solomon DA, Fiedorowicz JG, Endicott J, Schettler PJ, Judd LL. Anxiety and outcome in bipolar disorder. Am J Psychiatry 2009; 166: 1238-1243.
31. El-Mallakh RS, Hollifield M. Comorbid anxiety in bipolar disorder alters treatment and prognosis. Psychiatr Q 2008; 79: 139-150.
32. Henry C, Van den Bulke D, Bellivier F, Etain B, Rouillon F, Leboyer M. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer. J Clin Psychiatry 2003; 64: 331-335.
33. Lee JH, Dunner DL. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders. Depress Anxiety 2008; 25: 91-97.
34. Azorin JM, Kaladjian A, Adida M et al. Psychopathological correlates of lifetime anxiety comorbidity in bipolar I patients: findings from a French national cohort. Psychopathology 2009; 42: 380-386.
35. Duschek S, Muckenthaler M, Werner N, del Paso GA. Relationships between features of autonomic cardiovascular control and cognitive performance. Biol Psychol 2009; 81: 110-117.
36. Beaudreau SA, O'Hara R. The association of anxiety and depressive symptoms with cognitive performance in community-dwelling older adults. Psychol Aging 2009; 24: 507-512.
37. Miu AC, Heilman RM, Houser D. Anxiety impairs decision-making: psychophysiological evidence from an Iowa Gambling Task. Biol Psychol 2008; 77: 353-358.
38. Schwerdtfeger A. Trait anxiety and autonomic indicators of the processing of threatening information: a cued S1-S2 paradigm. Biol Psychol 2006; 72: 59-66.
39. Lee BK, Glass TA, McAtee MJ et al. Associations of salivary cortisol with cognitive function in the Baltimore memory study. Arch Gen Psychiatry 2007; 64: 810-818.
40. Silva LT, Leite JR. Physiological modifications and increase in state anxiety in volunteers submitted to the Stroop Color-Word Interference Test: a preliminary study. Physiol Behav 2000; 70: 113-118.
41. Kobayashi N, Yoshino A, Takahashi Y, Nomura S. Autonomic arousal in cognitive conflict resolution. Auton Neurosci 2007; 132: 70-75.
42. Fertuck EA, Marsano-Jozefowicz S, Stanley B et al. The impact of borderline personality disorder and anxiety on neuropsychological performance in major depression. J Pers Disord 2006; 20: 55-70.
43. Fishbein D, Hyde C, Eldreth D et al. Cognitive performance and autonomic reactivity in abstinent drug abusers and nonusers. Exp Clin Psychol 2005; 13: 25.
44. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for Axis I DSM-IV Disorders-Patients Edition (SCID-I/P), Version 2.0. New York: Biometric Research, New York State Psychiatric Institute, 1994.
45. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J Pers Assess 1996; 67: 588-597.
46. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio: Psychological Corporation, 1996.
47. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
48. Spielberger CD, Gorsuch RL, Lushene PR, Jacobs GA. State-Trait Anxiety Inventory for Adults. Manual, Instrument and Scoring Guide. Palo Alto, CA: Consulting Psychologists Press, Inc., 1983.
49. Babor TF, De La Fuente JR, Saunders J, Grant M. AUDIT: The Alcohol Use Disorders Identification Test. Guidelines for Use in Primary Health Care. Geneva: World Health Organization, 1987.
50. Berner MM, Kriston L, Bentele M, Härter M. The alcohol use disorders identification test for detecting at-risk drinking: a systematic review and meta-analysis. J Stud Alcohol Drugs 2007; 68: 461-473.
51. Yudko E, Lozhkina O, Fouts A. A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. J Subst Abuse Treat 2007; 32: 189-198.
52. Wechsler D. Wechsler Abbreviated Scale of Intelligence. San Antonio: The Psychological Cooperation, 1999.
53. O'Halloran JP, Kemp A, Gooch KN et al. Psychometric comparison of computerized and standard administration of neurocognitive assessment instrument selected by the CATIE and MATRICS consortia among patients with schizophrenia. Schizophr Res 2008; 106: 33-41.
54. Gualtieri CT, Johnson LG. Age-related cognitive decline in patients with mood disorders. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 962-967.
55. Goldberg JF, Burdick KE. Cognitive Dysfunction in Bipolar Disorder: A Guide for Clinicians. Arlington: American Psychiatric Publishing, Inc., 2008.
56. Boylan KR, Bieling PJ, Marriott M, Begin H, Young LT, MacQueen GM. Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder. J Clin Psychiatry 2004; 65: 1106-1113.
57. Lezak MD, Howieson DB, Loring DW, Hannay HJ. Neuropsychological Assessment. New York: Oxford University Press, Inc., 2004.
58. Martinez-Aran A, Vieta E, Torrent C et al. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord 2007; 9: 103-113.
59. Mur M, Portella MJ, Martinez-Aran A, Pifarre J, Vieta E. Influence of clinical and neuropsychological variables on the psychosocial and occupational outcome of remitted bipolar patients. Psychopathology 2009; 42: 148-156.
60. Berk M, Ng F, Wang WV et al. The empirical redefinition of the psychometric criteria for remission in bipolar disorder. J Affect Disord 2008; 106: 153-158.